Cardiff Oncology, Inc. ( CRDF) - Stock Earnings
CRDF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CRDF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -7.2 million USD | 243000 USD |
| 2026Q1 | -12.3 million USD | 41000 USD |
| 2026Q2 | -9.2 million USD | 104000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CRDF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -41.4 million USD | 488000 USD |
| 2024 | -45.4 million USD | 683000 USD |
| 2025 | -45.9 million USD | 593000 USD |
| 2026 Est. | — | — |
CRDF
Price: $1.01
Earnings Per Share: -0.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 531000
Market Capitalization: 87.9 million